NASDAQ · Biotechnology

ABCL (ABCL) Stock

$6.93 +6.13% NASDAQ: ABCL Healthcare

Valuation

MetricValue
Price$6.93
Market Cap$2.12B
P/E Ratio-5.91
P/B Ratio1.54
P/S Ratio19.08
EPS (TTM)$-0.84
52-Week High$8.39
52-Week Low$2.75
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.47%
ROA-9.99%
ROCE-19.02%
Gross Margin89.50%
Operating Margin-2.68%
Net Margin-1.82%
Debt/Equity0.14
Current Ratio11.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$375.0M$485.0M$38.0M$29.0M$75.0M
Operating Profit$204.0M$217.0M$-237.0M$-315.0M$-217.0M
Net Profit$153.0M$159.0M$-146.0M$-163.0M$-146.0M
EPS$0.48$0.50$-0.51$-0.55$-0.49
Op Margin54.5%44.6%-623.8%-1091.7%-289.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.3B$1.5B$1.5B$1.4B$1.4B
Total Liabilities$293.0M$308.0M$336.0M$304.0M$216.0M
Cash$476.0M$387.0M$133.0M$156.0M$155.0M
Borrowings$40.0M$82.0M$77.0M$65.0M$143.0M

Latest News

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 CNW Group · Jul 15, 2026 AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026 Business Wire · Jul 7, 2026 Are You Looking for a Top Momentum Pick? Why AbCellera Biologics Inc. (ABCL) is a Great Choice Zacks · Jul 7, 2026 Benchmark Upgrades AbCellera Biologics to Buy From Hold, Price Target is $11 MT Newswires · Jul 7, 2026 AbCellera Appoints Dr. Lynn Seely to its Board of Directors Business Wire · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$245.0M$277.0M$-44.0M$-109.0M$-131.0M
Investing Cash Flow$-391.0M$-425.0M$-299.0M$43.0M$45.0M
Financing Cash Flow$-8.0M$-4.0M$-1.0M$-1.0M$14.0M
Net Cash Flow$-93.0M$-86.0M$-254.0M$23.0M$-28.0M
Free Cash Flow$186.0M$205.0M$-121.0M$-187.0M$-174.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-58.53
EV / EBITDA-6.16
FCF Yield-12.52%
Quick Ratio14.05
Interest Coverage—
Return 1Y13.13%
Return 3Y-26.21%
Return 5Y-64.25%

Ownership

Insiders Held23.04%
Institutions Held42.57%
Institutions Float Held55.32%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP30,275,9382026-03-31
Capital World Investors13,361,0962026-03-31
Two Sigma Investments, LP10,562,0652026-03-31
TD Waterhouse Canada Inc.9,564,6592026-03-31
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC7,575,4762026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BHVN $14.07 +3.19% -6.11 $2.12B 0.00%
CLDX $35.80 +0.63% -7.84 $2.38B 0.00%
IMNM $23.22 +2.83% -8.13 $2.22B 0.00%
JANX $16.04 +0.25% -7.78 $978.19M 0.00%
NUVB $6.58 -1.28% -8.15 $2.28B 0.00%

About ABCL

ABCL is led by CEO Carl Hansen, employs 596 people, headquartered in CA, publicly traded since 2020.

ABCL stock trades at $6.93 with a market capitalization of $2.12B. The stock is valued at a price-to-earnings (P/E) ratio of -5.91, price-to-book of 1.54, price-to-sales of 19.08. Over the past 52 weeks the stock has ranged between $2.75 and $8.39, and currently trades 17.4% below its 52-week high.

On profitability, ABCL generates a return on equity (ROE) of -14.47%, return on capital employed of -19.02%, an operating margin of -2.68%, a net profit margin of -1.82%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides